Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study

  1. Nahi, H.
  2. Usmani, S.Z.
  3. Mateos, M.-V.
  4. van de Donk, N.W.C.J.
  5. Oriol, A.
  6. Plesner, T.
  7. Bandyopadhyay, N.
  8. Hellemans, P.
  9. Tromp, B.
  10. Nnane, I.
  11. Zemlickis, D.
  12. Chari, A.
  13. Moreau, P.
Aldizkaria:
Leukemia and Lymphoma

ISSN: 1029-2403,  1042-8194

Argitalpen urtea: 2023

Alea: 64

Zenbakia: 2

Orrialdeak: 468-472

Mota: Gutuna

DOI: 10.1080/10428194.2022.2148221 GOOGLE SCHOLAR lock_openSarbide irekia editor